Cycurion shares surge 21.59% premarket after regaining Nasdaq bid price compliance, canceling hearing.

Cycurion surged 21.59% in premarket trading after announcing it has regained compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5450(a)(1). The company confirmed that the previously scheduled Nasdaq Hearings Panel review on November 20, 2025, has been canceled, ensuring uninterrupted trading of its shares. The resolution removes the risk of delisting, which had previously threatened liquidity and investor confidence. Nasdaq’s confirmation of compliance and the cancellation of the hearing were highlighted as critical developments, allowing Cycurion to focus on strategic priorities and long-term shareholder value. The stock’s sharp rise reflects investor relief over the regulatory uncertainty being resolved, with analysts noting the positive market reaction to the company’s ability to maintain its Nasdaq listing.